Macakurzin C Derivatives as a Novel Pharmacophore for Pan-Peroxisome Proliferator-Activated Receptor Modulator

Biomol Ther (Seoul). 2023 May 1;31(3):312-318. doi: 10.4062/biomolther.2022.097. Epub 2022 Nov 16.

Abstract

The natural flavonoid macakurzin C (1) exhibited adiponectin biosynthesis-inducing activity during adipogenesis in human bone marrow mesenchymal stem cells and its molecular mechanism was directly associated with a pan-peroxisome proliferator-activated receptor (PPAR) modulator affecting all three PPAR subtypes α, γ, and δ. In this study, increases in adiponectin biosynthesis-inducing activity by macakurzin C derivatives (2-7) were studied. The most potent adiponectin biosynthesis-inducing compound 6, macakurzin C 3,5-dimethylether, was elucidated as a dual PPARα/γ modulator. Compound 6 may exhibit the most potent activity because of the antagonistic relationship between PPARδ and PPARγ. Docking studies revealed that the O-methylation of macakurzin C to generate compound 6 significantly disrupted PPARδ binding. Compound 6 has therapeutic potential in hypoadiponectinemia-related metabolic diseases.

Keywords: Adiponectin; Human bone marrow mesenchymal stem cells; Macakurzin C derivative; PPARα/γ dual modulator; Peroxisome proliferator-activated receptor.

Grants and funding

ACKNOWLEDGMENTS This study was supported by the National Research Foundation of Korea (NRF) grants funded by the Korea government (MSIT) [NRF-2019R1A2C2085749, NRF-2022M3A9B6017654, and NRF-2020R1A2C2010329].